We’re passionate about supporting your success when it comes to diagnosing and treating canine osteoarthritis (OA). With the materials and tools on this page, you’ll have the important resources you need to provide your patients with high-quality care.
Supporting your patients with canine OA starts with understanding, assessing and treating their condition from the moment it starts.
Screen from a young age
Treat OA at its earliest diagnosed stage*
Prescribe Galliprant® (grapiprant tablets) for safe and effective pain relief
Help your patients maintain an active life by establishing Galliprant as your partner in delivering OA pain relief.*The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg).
Use the resources below to help you provide the highest quality of care and identify canine OA at its earliest diagnosed stages.
COAST is an innovative canine OA staging tool designed by a consortium of international experts in veterinary surgery and pain management. With COAST, you can start the conversation about canine OA with pet owners before it sets in, and monitor OA over time.
See how veterinarians are taking the right steps toward delivering effective pain relief for their patients with canine OA.
Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.
Not for use in humans. For use in dogs only. Keep this and all medications out of reach of children and pets. Store out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose. Do not use in dogs that have a hypersensitivity to grapiprant. If Galliprant is used long term, appropriate monitoring is recommended. Concomitant use of Galliprant with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite, and lethargy. Click here for full prescribing information.
Contact your Elanco or distributor representative, or call Elanco (1-888-545-5973) to discover how you can incorporate Galliprant into your canine OA protocol today.